FIGURE 1.

Behaviour of COVID-19 across the two populations over the months of the pandemic. A, Absolute numbers of new cases of COVID-19, prevalence rates, and major demographic characteristics. B, COVID-19–related lethality rates in kidney transplant recipients (orange lines/columns) and in the comparator group of the general population of Ipaussu (dark green lines/columns). The study period was arbitrarily split into era 1, “pre-Omicron,” and era 2, “post-Omicron.” According to the National Immunization Program, the first dose of vaccines that were anti–SARS-CoV-2 were made available since January 2021 and the third dose of vaccine from August 2021. COVID-19, coronavirus disease 2019; IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.